Role of the ACCM
The Advisory Committee on Complementary Medicines (ACCM) provides expert advice at the request of the Minister or Secretary for Health, on the safety, efficacy and manufacturing quality of a complementary medicine in the Australian Register of Therapeutic Goods.
ACCM was formed in January 2010 under Regulation 39 of the Therapeutic Goods Regulations 1990 and the members are appointed by the Minister for Health.
ACCM supersedes the Complementary Medicines Evaluation Committee (CMEC) and has an increased focus on the advisory role within the regulatory framework of complementary medicines.
Membership comprises of professionals with specific scientific, medical, clinical expertise as well as appropriate consumer health issues relating to complementary medicines.
Membership
The current membership of the committee can be found on our ACCM members page.
Contact details for the ACCM
| ACCM enquiries | Committee support enquiries | |
|---|---|---|
| complementary.medicines@health.gov.au | Committees@health.gov.au | |
| Phone | +61 2 6289 4627 | |
| Postal Address | Advisory Committee on Complementary Medicines Therapeutic Goods Administration PO Box 100 WODEN ACT 2606 Attn: Complementary and OTC Medicines Branch, MDP 122 |
Committee Support Unit Therapeutic Goods Administration PO Box 100 WODEN ACT 2606 Attn: Collaboration Services Section, MDP 122 |
Outcomes
- ACCM meeting statement, Meeting 30, 3 November 2022Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 3 November 2022
- ACCM meeting statement, Meeting 29, 17 March 2022Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 17 March 2022
- ACCM meeting statement, Meeting 28, 15 July 2021Meeting statementsA meeting statement is now available for the last Advisory Committee on Complementary Medicines meeting